Pediatric Continuity Care Intensivist

NACompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Critical Illness
Interventions
BEHAVIORAL

Continuity Care Intensivist Communication Training

Physicians enrolled in the intervention arm will complete a two to three part communication training. Survey measures of communication competency and burnout will be administered at baseline, after training, and at the end of the study. After the communication training, physicians will undergo an OSCE assessment with a simulated patient to evaluate communication skills. At the end of the study, CCI providers will receive surveys that assess the experience and challenges of the role, repeat surveys assessing competency with communication and frequency of engaging families in goals of care conversations, in addition to a follow-up focus group that will assess their experience with the intervention, the time required and the potential tradeoffs in other duties required by them to participate as a CCI.

BEHAVIORAL

Continuity Care Intensivist (CCI) Provider Program

"After undergoing CCI training, CCI providers will fulfill a standardized role with parent-patient dyads:~* CCI will meet with families on a regular basis and at change of physician of record throughout their entire PICU hospitalization.~* Help patients/families navigate decisions in concert with preferences and beliefs~* Help patients/families and other care providers look at bigger picture; trajectory of illness, goals, and hopes for the patient.~* Serve as point person for active intensivists on service and other specialists~* Help resolve conflict when multiple providers have different opinions on course of action"

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT02146573 - Pediatric Continuity Care Intensivist | Biotech Hunter | Biotech Hunter